Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003993
What this trial is testing

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institute on Aging (NIA) 24
Early research (Phase 1)Active Not RecruitingNCT03598244
What this trial is testing

Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Who this might be right for
Recurrent Diffuse Intrinsic Pontine GliomaRecurrent Malignant GliomaRecurrent Medulloblastoma+5 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Early research (Phase 1)Active Not RecruitingNCT03696030
What this trial is testing

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Leptomeninges+2 more
City of Hope Medical Center 24
Early research (Phase 1)Study completedNCT05169944
What this trial is testing

Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors

Who this might be right for
Brain CancerMalignant Brain TumorRecurrent Brain Tumor+3 more
University of California, San Francisco 13
Testing effectiveness (Phase 2)Ended earlyNCT01229644
What this trial is testing

Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas

Who this might be right for
Glioma
Arog Pharmaceuticals, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04659811
What this trial is testing

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Who this might be right for
Grade I Meningioma, AdultGrade II Meningioma, AdultGrade III Meningioma, Adult+1 more
Nancy Ann Oberheim Bush, MD 35
Testing effectiveness (Phase 2)Ended earlyNCT00003911
What this trial is testing

S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases

Who this might be right for
Melanoma (Skin)Metastatic Cancer
SWOG Cancer Research Network 2
Early research (Phase 1)Ended earlyNCT01103375
What this trial is testing

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Study completedNCT01498328
What this trial is testing

Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

Who this might be right for
GlioblastomaSmall Cell GlioblastomaGiant Cell Glioblastoma+4 more
Celldex Therapeutics 127
Very early researchEnded earlyNCT04424966
What this trial is testing

Infigratinib in Recurrent High-Grade Glioma Patients

Who this might be right for
GliomaGlioblastomaGBM
Nader Sanai 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Not applicableNo Longer AvailableNCT02755987
What this trial is testing

Expanded Access to ANG1005 for Individual Patients

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaBreast Cancer With Recurrent Brain Metastases+1 more
Angiochem Inc
Early research (Phase 1)Ended earlyNCT03967093
What this trial is testing

BXQ-350 in Children and Young Adults With Relapsed Solid Tumors

Who this might be right for
Neoplasms
Bexion Pharmaceuticals, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00002814
What this trial is testing

Combination Chemotherapy for Patients With Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01756352
What this trial is testing

FET-PET for Evaluation of Response of Recurrent GBM to Avastin

Who this might be right for
Glioblastoma MultiformeGBM
Marcelo F. Di Carli, MD, FACC 13
Early research (Phase 1)Study completedNCT00107458
What this trial is testing

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 26
Not applicableStudy completedNCT02167204
What this trial is testing

18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors

Who this might be right for
Metastatic Malignant Neoplasm in the BrainPrimary Brain NeoplasmRecurrent Brain Neoplasm
University of Washington 9
Not applicableStudy completedNCT03841435
What this trial is testing

Hypofractionated Radiotherapy for Recurrent DIPG

Who this might be right for
Recurrent Diffuse Intrinsic Pontine Glioma
University of Cincinnati 5
Testing effectiveness (Phase 2)Study completedNCT01648348
What this trial is testing

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 116
Next Page